BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maurya DK, Bandekar M, Sandur SK. Soluble factors secreted by human Wharton’s jelly mesenchymal stromal/stem cells exhibit therapeutic radioprotection: A mechanistic study with integrating network biology. World J Stem Cells 2022; 14(5): 347-361 [PMID: 35722198 DOI: 10.4252/wjsc.v14.i5.347]
URL: https://www.wjgnet.com/1948-0210/full/v14/i5/347.htm
Number Citing Articles
1
Prashasti Sharma, Dharmendra Kumar Maurya. Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injuryWorld Journal of Stem Cells 2024; 16(7): 742-759 doi: 10.4252/wjsc.v16.i7.742
2
Kate Hurley, Rachel Clow, Ashok Jadhav, Edouard I. Azzam, Yi Wang. Mitigation of acute radiation syndrome (ARS) with human umbilical cord bloodInternational Journal of Radiation Biology 2024; 100(3): 317 doi: 10.1080/09553002.2023.2277372
3
Jiah Shin Chin, Mandy Li Ling Tan, Priscilla Lay Keng Lim, Bhavya Sharma, Aimin Yeo, Yi Bing Aw, Yi Zhen Ng, Carine Bonnard, David L. Becker, Pamela Mok. Secretome from prolonged high‐density human Wharton's jelly stem cell culture accelerates wound healing in both in vitro and in vivo modelsInternational Wound Journal 2025; 22(5) doi: 10.1111/iwj.70033
4
Dharmendra Kumar Maurya, Santosh Kumar Sandur. Future Perspectives of Wharton’s Jelly Mesenchymal Stem Cells and their Soluble Factors in RadioprotectionCurrent Stem Cell Research & Therapy 2024; 19(6): 781 doi: 10.2174/1574888X18666230119103905